Suppressor of Variegation 3-9 Homolog 2, a Novel Binding Protein of Translationally Controlled Tumor Protein, Regulates Cancer Cell Proliferation |
Kim, A-Reum
(Division of Translational Science, Research Institute, National Cancer Center)
Sung, Jee Young (Division of Clinical Research, Research Institute, National Cancer Center) Rho, Seung Bae (Division of Translational Science, Research Institute, National Cancer Center) Kim, Yong-Nyun (Division of Translational Science, Research Institute, National Cancer Center) Yoon, Kyungsil (Division of Translational Science, Research Institute, National Cancer Center) |
1 | Yarm, F. R. (2002) Plk phosphorylation regulates the microtubule-stabilizing protein TCTP. Mol. Cell. Biol. 22, 6209-6221. DOI |
2 | Miao, X., Chen, Y. B., Xu, S. L., Zhao, T., Liu, J. Y., Li, Y. R., Wang, J., Zhang, J. and Guo, G. Z. (2013) TCTP overexpression is associated with the development and progression of glioma. Tumour Biol. 34, 3357-3361. DOI |
3 | Narita, M., Nunez, S., Heard, E., Narita, M., Lin, A. W., Hearn, S. A., Spector, D. L., Hannon, G. J. and Lowe, S. W. (2003) Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence. Cell, 113, 703-716. DOI |
4 | Nielsen, S. J., Schneider, R., Bauer, U. M., Bannister, A. J., Morrison, A., O'Carroll, D., Firestein, R., Cleary, M., Jenuwein, T., Herrera, R. E. and Kouzarides, T. (2001) Rb targets histone H3 methylation and HP1 to promoters. Nature 412, 561-565. DOI |
5 | O'Carroll, D., Scherthan, H., Peters, A. H., Opravil, S., Haynes, A. R., Laible, G., Rea, S., Schmid, M., Lebersorger, A., Jerratsch, M., Sattler, L., Mattei, M. G., Denny, P., Brown, S. D., Schweizer, D. and Jenuwein, T. (2000) Isolation and characterization of Suv39h2, a second histone H3 methyltransferase gene that displays testisspecific expression. Mol. Cell. Biol. 20, 9423-9433. DOI |
6 | Yoon, K. A., Hwangbo, B., Kim, I. J., Park, S., Kim, H. S., Kee, H. J., Lee, J. E., Jang, Y. K., Park, J. G. and Lee, J. S. (2006) Novel polymorphisms in the SUV39H2 histone methyltransferase and the risk of lung cancer. Carcinogenesis 27, 2217-2222. DOI |
7 | Zhang, F., Liu, B., Wang, Z., Yu, X. J., Ni, Q. X., Yang, W. T., Mukaida, N. and Li, Y. Y. (2013) A novel regulatory mechanism of Pim-3 kinase stability and its involvement in pancreatic cancer progression. Mol. Cancer Res. 11, 1508-1520. DOI |
8 | Zheng, Y., Li, B., Wang, J., Xiong, Y., Wang, K., Qi, Y., Sun, H., Wu, L. and Yang, L. (2018) Identification of SUV39H2 as a potential oncogene in lung adenocarcinoma. Clin. Epigenetics 10, 129. DOI |
9 | Pickart, C. M. (2001) Mechanisms underlying ubiquitination. Annu. Rev. Biochem. 70, 503-533. DOI |
10 | Peters, A. H., O'Carroll, D., Scherthan, H., Mechtler, K., Sauer, S., Schofer, C., Weipoltshammer, K., Pagani, M., Lachner, M., Kohlmaier, A., Opravil, S., Doyle, M., Sibilia, M. and Jenuwein, T. (2001) Loss of the Suv39h histone methyltransferases impairs mammalian heterochromatin and genome stability. Cell 107, 323-337. DOI |
11 | Rao, V. K., Pal, A. and Taneja, R. (2017) A drive in SUVs: from development to disease. Epigenetics 12, 177-186. DOI |
12 | Rea, S., Eisenhaber, F., O'Carroll, D., Strahl, B. D., Sun, Z. W., Schmid, M., Opravil, S., Mechtler, K., Ponting, C. P., Allis, C. D. and Jenuwein, T. (2000) Regulation of chromatin structure by site-specific histone H3 methyltransferases. Nature 406, 593-599. DOI |
13 | Susini, L., Besse, S., Duflaut, D., Lespagnol, A., Beekman, C., Fiucci, G., Atkinson, A. R., Busso, D., Poussin, P., Marine, J. C., Martinou, J. C., Cavarelli, J., Moras, D., Amson, R. and Telerman, A. (2008) TCTP protects from apoptotic cell death by antagonizing bax function. Cell Death Differ. 15, 1211-1220. DOI |
14 | Rho, S. B., Lee, J. H., Park, M. S., Byun, H. J., Kang, S., Seo, S. S., Kim, J. Y. and Park, S. Y. (2011) Anti-apoptotic protein TCTP controls the stability of the tumor suppressor p53. FEBS Lett. 585, 29-35. DOI |
15 | Rho, S. B., Lee, K. H., Kim, J. W., Shiba, K., Jo, Y. J. and Kim, S. (1996) Interaction between human tRNA synthetases involves repeated sequence elements. Proc. Natl. Acad. Sci. U.S.A. 93, 10128-10133. DOI |
16 | Shuai, W., Wu, J., Chen, S., Liu, R., Ye, Z., Kuang, C., Fu, X., Wang, G., Li, Y., Peng, Q., Shi, W., Li, Y., Zhou, Q. and Huang, W. (2018) SUV39H2 promotes colorectal cancer proliferation and metastasis via tri-methylation of the SLIT1 promoter. Cancer Lett. 422, 56-69. DOI |
17 | Albacker, C. E., Storer, N. Y., Langdon, E. M., Dibiase, A., Zhou, Y., Langenau, D. M. and Zon, L. I. (2013) The histone methyltransferase SUV39H1 suppresses embryonal rhabdomyosarcoma formation in zebrafish. PLoS ONE 8, e64969. DOI |
18 | Acunzo, J., Baylot, V., So, A. and Rocchi, P. (2014) TCTP as therapeutic target in cancers. Cancer Treat. Rev. 40, 760-769. DOI |
19 | Adams, J. (2004) The development of proteasome inhibitors as anticancer drugs. Cancer Cell 5, 417-421. DOI |
20 | Ait-Si-Ali, S., Guasconi, V., Fritsch, L., Yahi, H., Sekhri, R., Naguibneva, I., Robin, P., Cabon, F., Polesskaya, A. and Harel-Bellan, A. (2004) A Suv39h-dependent mechanism for silencing S-phase genes in differentiating but not in cycling cells. EMBO J. 23, 605-615. DOI |
21 | Amson, R., Pece, S., Lespagnol, A., Vyas, R., Mazzarol, G., Tosoni, D., Colaluca, I., Viale, G., Rodrigues-Ferreira, S., Wynendaele, J., Chaloin, O., Hoebeke, J., Marine, J. C., Di Fiore, P. P. and Telerman, A. (2011) Reciprocal repression between P53 and TCTP. Nat. Med. 18, 91-99. DOI |
22 | Amson, R., Pece, S., Marine, J. C., Di Fiore, P. P. and Telerman, A. (2013) TPT1/ TCTP-regulated pathways in phenotypic reprogramming. Trends Cell Biol. 23, 37-46. DOI |
23 | Amzallag, N., Passer, B. J., Allanic, D., Segura, E., Thery, C., Goud, B., Amson, R. and Telerman, A. (2004) TSAP6 facilitates the secretion of translationally controlled tumor protein/histamine-releasing factor via a nonclassical pathway. J. Biol. Chem. 279, 46104-46112. DOI |
24 | Chen, K., Chen, S., Huang, C., Cheng, H. and Zhou, R. (2013) TCTP increases stability of hypoxia-inducible factor 1alpha by interaction with and degradation of the tumour suppressor VHL. Biol. Cell 105, 208-218. DOI |
25 | Bannister, A. J., Zegerman, P., Partridge, J. F., Miska, E. A., Thomas, J. O., Allshire, R. C. and Kouzarides, T. (2001) Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain. Nature 410, 120-124. DOI |
26 | Bommer, U. A. and Thiele, B. J. (2004) The translationally controlled tumour protein (TCTP). Int. J. Biochem. Cell Biol. 36, 379-385. DOI |
27 | Bommer, U. A., Vine, K. L., Puri, P., Engel, M., Belfiore, L., Fildes, K., Batterham, M., Lochhead, A. and Aghmesheh, M. (2017) Translationally controlled tumour protein TCTP is induced early in human colorectal tumours and contributes to the resistance of HCT116 colon cancer cells to 5-FU and oxaliplatin. Cell Commun. Signal. 15, 9. DOI |
28 | Burgess, A., Labbe, J. C., Vigneron, S., Bonneaud, N., Strub, J. M., Van Dorsselaer, A., Lorca, T. and Castro, A. (2008) Chfr interacts and colocalizes with TCTP to the mitotic spindle. Oncogene 27, 5554-5566. DOI |
29 | Cans, C., Passer, B. J., Shalak, V., Nancy-Portebois, V., Crible, V., Amzallag, N., Allanic, D., Tufino, R., Argentini, M., Moras, D., Fiucci, G., Goud, B., Mirande, M., Amson, R. and Telerman, A. (2003) Translationally controlled tumor protein acts as a guanine nucleotide dissociation inhibitor on the translation elongation factor eEF1A. Proc. Natl. Acad. Sci. U.S.A. 100, 13892-13897. DOI |
30 | Chen, S. H., Wu, P. S., Chou, C. H., Yan, Y. T., Liu, H., Weng, S. Y. and Yang-Yen, H. F. (2007) A knockout mouse approach reveals that TCTP functions as an essential factor for cell proliferation and survival in a tissue- or cell type-specific manner. Mol. Biol. Cell 18, 2525-2532. DOI |
31 | Chiba, T., Saito, T., Yuki, K., Zen, Y., Koide, S., Kanogawa, N., Motoyama, T., Ogasawara, S., Suzuki, E., Ooka, Y., Tawada, A., Otsuka, M., Miyazaki, M., Iwama, A. and Yokosuka, O. (2015) Histone lysine methyltransferase SUV39H1 is a potent target for epigenetic therapy of hepatocellular carcinoma. Int. J. Cancer 136, 289-298. DOI |
32 | Ciechanover, A. (1994) The ubiquitin-proteasome proteolytic pathway. Cell 79, 13-21. DOI |
33 | Gnanasekar, M., Thirugnanam, S., Zheng, G., Chen, A. and Ramaswamy, K. (2009) Gene silencing of translationally controlled tumor protein (TCTP) by siRNA inhibits cell growth and induces apoptosis of human prostate cancer cells. Int. J. Oncol. 34, 1241-1246. |
34 | Deng, S. S., Xing, T. Y., Zhou, H. Y., Xiong, R. H., Lu, Y. G., Wen, B., Liu, S. Q. and Yang, H. J. (2006) Comparative proteome analysis of breast cancer and adjacent normal breast tissues in human. Genomics Proteomics Bioinformatics 4, 165-172. DOI |
35 | Fiucci, G., Lespagnol, A., Stumptner-Cuvelette, P., Beaucourt, S., Duflaut, D., Susini, L., Amson, R. and Telerman, A. (2003) Genomic organization and expression of mouse Tpt1 gene. Genomics 81, 570-578. DOI |
36 | Gachet, Y., Tournier, S., Lee, M., Lazaris-Karatzas, A., Poulton, T. and Bommer, U. A. (1999) The growth-related, translationally controlled protein P23 has properties of a tubulin binding protein and associates transiently with microtubules during the cell cycle. J. Cell Sci. 112, 1257-1271. DOI |
37 | Kubiak, J. Z., Bazile, F., Pascal, A., Richard-Parpaillon, L., Polanski, Z., Ciemerych, M. A. and Chesnel, F. (2008) Temporal regulation of embryonic M-phases. Folia Histochem. Cytobiol. 46, 5-9. |
38 | Gyorffy, B., Surowiak, P., Budczies, J. and Lanczky, A. (2013) Online survival analysis software to assess the prognostic value of biomarkers using transcriptomic data in non-small-cell lung cancer. PLoS ONE 8, e82241. DOI |
39 | Kang, H. S., Lee, M. J., Song, H., Han, S. H., Kim, Y. M., Im, J. Y. and Choi, I. (2001) Molecular identification of IgE-dependent histaminereleasing factor as a B cell growth factor. J. Immunol. 166, 6545-6554. DOI |
40 | Koziol, M. J., Garrett, N. and Gurdon, J. B. (2007) Tpt1 activates transcription of oct4 and nanog in transplanted somatic nuclei. Curr. Biol. 17, 801-807. DOI |
41 | Tuynder, M., Fiucci, G., Prieur, S., Lespagnol, A., Geant, A., Beaucourt, S., Duflaut, D., Besse, S., Susini, L., Cavarelli, J., Moras, D., Amson, R. and Telerman, A. (2004) Translationally controlled tumor protein is a target of tumor reversion. Proc. Natl. Acad. Sci. U.S.A. 101, 15364-15369. DOI |
42 | Tani, T., Shimada, H., Kato, Y. and Tsunoda, Y. (2007) Bovine oocytes with the potential to reprogram somatic cell nuclei have a unique 23-kDa protein, phosphorylated transcriptionally controlled tumor protein (TCTP). Cloning Stem Cells 9, 267-280. DOI |
43 | Telerman, A. and Amson, R. (2009) The molecular programme of tumour reversion: the steps beyond malignant transformation. Nat. Rev. Cancer 9, 206-216. DOI |
44 | Thebault, S., Agez, M., Chi, X., Stojko, J., Cura, V., Telerman, S. B., Maillet, L., Gautier, F., Billas-Massobrio, I., Birck, C., Troffer-Charlier, N., Karafin, T., Honore, J., Senff-Ribeiro, A., Montessuit, S., Johnson, C. M., Juin, P., Cianferani, S., Martinou, J. C., Andrews, D. W., Amson, R., Telerman, A. and Cavarelli, J. (2016) TCTP contains a BH3-like domain, which instead of inhibiting, activates BclxL. Sci. Rep. 6, 19725. DOI |
45 | Tuynder, M., Susini, L., Prieur, S., Besse, S., Fiucci, G., Amson, R. and Telerman, A. (2002) Biological models and genes of tumor reversion: cellular reprogramming through tpt1/TCTP and SIAH-1. Proc. Natl. Acad. Sci. U.S.A. 99, 14976-14981. DOI |
46 | Vandel, L., Nicolas, E., Vaute, O., Ferreira, R., Ait-Si-Ali, S. and Trouche, D. (2001) Transcriptional repression by the retinoblastoma protein through the recruitment of a histone methyltransferase. Mol. Cell. Biol. 21, 6484-6494. DOI |
47 | MacDonald, S. M., Rafnar, T., Langdon, J. and Lichtenstein, L. M. (1995) Molecular identification of an IgE-dependent histaminereleasing factor. Science 269, 688-690. DOI |
48 | Lachner, M., O'Carroll, D., Rea, S., Mechtler, K. and Jenuwein, T. (2001) Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins. Nature 410, 116-120. DOI |
49 | Li, F., Zhang, D. and Fujise, K. (2001) Characterization of fortilin, a novel antiapoptotic protein. J. Biol. Chem. 276, 47542-47549. DOI |
50 | Liu, H., Peng, H. W., Cheng, Y. S., Yuan, H. S. and Yang-Yen, H. F. (2005) Stabilization and enhancement of the antiapoptotic activity of mcl-1 by TCTP. Mol. Cell. Biol. 25, 3117-3126. DOI |